Settings oncology. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases43

Neoplasms Genital Neoplasms, Female Lung Neoplasms Breast Neoplasms Neoplasm Recurrence, Local Precursor Cell Lymphoblastic Leukemia-Lymphoma Rhabdomyosarcoma Neutropenia Urogenital Neoplasms Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Radiation Injuries Neoplasm Metastasis Head and Neck Neoplasms Prostatic Neoplasms Disease Progression Bone Neoplasms Adenocarcinoma Brain Neoplasms Hematologic Diseases Recurrence Peritoneal Neoplasms Fatigue Urologic Neoplasms Wilms Tumor Nausea Pain Neuroblastoma Hepatoblastoma Carcinoma, Squamous Cell Sarcoma Vomiting Colorectal Neoplasms Carcinoma Fallopian Tube Neoplasms Uterine Cervical Neoplasms Kidney Neoplasms HIV Infections Endometrial Neoplasms Melanoma Lymphoma, Non-Hodgkin Anemia Thoracic Neoplasms

Chemicals and Drugs27

Antineoplastic Agents Cisplatin Vincristine Paclitaxel Doxorubicin Cyclophosphamide Carboplatin Etoposide Fluorouracil Prednisone Vinblastine Deoxycytidine Tumor Markers, Biological Ifosfamide Antibodies, Monoclonal, Humanized Taxoids Drugs, Investigational Antineoplastic Agents, Phytogenic Topotecan Mitolactol Antineoplastic Agents, Hormonal Antibodies, Monoclonal Asparaginase Antimetabolites, Antineoplastic Radiopharmaceuticals Cytarabine Dacarbazine

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Treatment Outcome Retrospective Studies Combined Modality Therapy Survival Analysis Disease-Free Survival Prognosis Palliative Care Prospective Studies Questionnaires Drug Administration Schedule Clinical Trials, Phase I as Topic Neoplasm Staging Survival Rate Clinical Trials, Phase III as Topic Follow-Up Studies Risk Factors Randomized Controlled Trials as Topic Drug Approval Radiotherapy Pilot Projects Feasibility Studies Reproducibility of Results Radiotherapy Dosage Chemotherapy, Adjuvant Research Design Cross-Sectional Studies Infusions, Intravenous Risk Assessment Patient Selection Remission Induction Sensitivity and Specificity Kaplan-Meier Estimate Clinical Trials, Phase II as Topic Individualized Medicine Predictive Value of Tests Terminal Care Radiotherapy, Adjuvant Multivariate Analysis Brachytherapy Data Collection Ambulatory Care Prevalence Multicenter Studies as Topic Dose Fractionation Positron-Emission Tomography Proportional Hazards Models Endpoint Determination Health Care Surveys Clinical Protocols Radiotherapy, Conformal Incidence Program Evaluation Mass Screening Tomography, X-Ray Computed Logistic Models Salvage Therapy Molecular Targeted Therapy Hospice Care Severity of Illness Index Treatment Failure Maximum Tolerated Dose Regression Analysis Administration, Oral Antineoplastic Protocols Case-Control Studies Interviews as Topic Focus Groups Chi-Square Distribution Diagnostic Imaging Patient Care Neoadjuvant Therapy Nontherapeutic Human Experimentation Therapeutic Touch Drug Evaluation Longitudinal Studies Cranial Irradiation Decision Support Techniques Complementary Therapies

Psychiatry and Psychology13

Attitude of Health Personnel Nurse's Role Physician-Patient Relations Decision Making Nurse-Patient Relations Interdisciplinary Communication Pain Disclosure Health Knowledge, Attitudes, Practice Focus Groups Patient Compliance Attitude to Health Cooperative Behavior

Phenomena and Processes8

Time Factors Sensitivity and Specificity Pain Dose-Response Relationship, Drug Maximum Tolerated Dose Algorithms Chi-Square Distribution Pregnancy

Disciplines and Occupations20

Medical Oncology Oncology Nursing Radiation Oncology Hematology Research Design Pediatrics Evidence-Based Medicine Individualized Medicine Health Physics Research Report Biomedical Research Research Nursing Research Translational Medical Research Nursing Methodology Research Evidence-Based Nursing Health Services Research Nontherapeutic Human Experimentation Pharmacogenetics Urology

Anthropology, Education, Sociology and Social Phenomena15

Quality of Life Drug Approval National Cancer Institute (U.S.)United States Food and Drug Administration Clinical Competence Patient Education as Topic Informed Consent Developing Countries Disclosure National Institutes of Health (U.S.)Education, Nursing, Continuing Therapeutic Misconception Social Support Forecasting Patient Advocacy

Technology, Industry, Agriculture1

Humanities3

Quality of Life Conflict of Interest Therapeutic Misconception

Information Science16

Questionnaires Survival Rate Data Collection Prevalence Research Report Interdisciplinary Communication Radiotherapy, Conformal Incidence Publications Algorithms Disclosure Interviews as Topic Focus Groups Workflow Databases, Factual Decision Support Techniques

Named Groups6

Infant, Newborn Outpatients Physicians Survivors Nursing Staff Health Personnel

Health Care107

Oncology Nursing Oncology Service, Hospital Cancer Care Facilities Societies, Medical Clinical Trials as Topic Treatment Outcome Retrospective Studies Survival Analysis Disease-Free Survival Palliative Care Prospective Studies Questionnaires Clinical Trials, Phase I as Topic Survival Rate Clinical Trials, Phase III as Topic Follow-Up Studies Risk Factors Practice Guidelines as Topic Randomized Controlled Trials as Topic National Cancer Institute (U.S.)Societies, Nursing Pilot Projects Feasibility Studies Reproducibility of Results Cross-Sectional Studies Patient Satisfaction Attitude of Health Personnel Risk Assessment Age Factors Patient Selection Nurse's Role Sensitivity and Specificity Kaplan-Meier Estimate Physician-Patient Relations Clinical Trials, Phase II as Topic United States Food and Drug Administration Quality Assurance, Health Care Referral and Consultation Predictive Value of Tests Cost-Benefit Analysis Quality of Health Care Nurse-Patient Relations Terminal Care Multivariate Analysis Radiation Injuries Primary Health Care Physicians Data Collection Ambulatory Care Prevalence Multicenter Studies as Topic Proportional Hazards Models Patient Care Planning Health Care Surveys Clinical Protocols Patient Care Team Incidence Congresses as Topic Program Evaluation Guideline Adherence Nursing Research Patient Participation Clinical Competence Mass Screening Logistic Models Hospitals, Pediatric Community Health Services Patient Education as Topic Nursing Staff Informed Consent Conflict of Interest Hospice Care Severity of Illness Index Treatment Failure Health Care Costs Guidelines as Topic Certification Health Services Accessibility Health Personnel Health Planning Guidelines Delivery of Health Care Regression Analysis Nursing Methodology Research Nursing Assessment Health Knowledge, Attitudes, Practice Standard of Care Antineoplastic Protocols Health Resources Sex Factors Case-Control Studies Interviews as Topic Focus Groups Chi-Square Distribution National Institutes of Health (U.S.)Patient Compliance Drug Costs Patient Care Physician's Practice Patterns Health Services Research Research Support as Topic Continuity of Patient Care Ambulatory Care Facilities Attitude to Health Academic Medical Centers Medical Audit Longitudinal Studies Patient Advocacy

Geographicals9

United States England Great Britain Japan Southwestern United States Europe Ontario Italy Canada

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Medical Oncology Oncology Nursing Radiation Oncology Oncology Service, Hospital Neoplasms Cancer Care Facilities Antineoplastic Combined Chemotherapy Protocols Societies, Medical Antineoplastic Agents Clinical Trials as Topic Treatment Outcome United States Retrospective Studies Combined Modality Therapy Survival Analysis Disease-Free Survival Hematology Prognosis Palliative Care Prospective Studies Questionnaires Drug Administration Schedule Clinical Trials, Phase I as Topic Neoplasm Staging Survival Rate Cisplatin Clinical Trials, Phase III as Topic Time Factors Genital Neoplasms, Female Lung Neoplasms Follow-Up Studies Vincristine Quality of Life Risk Factors Practice Guidelines as Topic Randomized Controlled Trials as Topic Breast Neoplasms Neoplasm Recurrence, Local Paclitaxel Drug Approval National Cancer Institute (U.S.)Radiotherapy Societies, Nursing Doxorubicin Pilot Projects Feasibility Studies Reproducibility of Results Radiotherapy Dosage Chemotherapy, Adjuvant Research Design Cross-Sectional Studies Cyclophosphamide Carboplatin Precursor Cell Lymphoblastic Leukemia-Lymphoma Infusions, Intravenous Etoposide Patient Satisfaction Attitude of Health Personnel Risk Assessment Rhabdomyosarcoma Age Factors Patient Selection Pediatrics Remission Induction Nurse's Role Sensitivity and Specificity Evidence-Based Medicine Neutropenia Fluorouracil Kaplan-Meier Estimate Physician-Patient Relations Urogenital Neoplasms Clinical Trials, Phase II as Topic United States Food and Drug Administration Quality Assurance, Health Care Infant, Newborn Individualized Medicine Ovarian Neoplasms Outpatients Referral and Consultation Predictive Value of Tests Cost-Benefit Analysis Prednisone Decision Making Carcinoma, Non-Small-Cell Lung Quality of Health Care Nurse-Patient Relations Terminal Care Radiotherapy, Adjuvant Multivariate Analysis Brachytherapy Radiation Injuries Vinblastine Primary Health Care Physicians Neoplasm Metastasis Health Physics Data Collection Drug Industry Ambulatory Care

No FAQ available that match "settings oncology"